Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Declines By 18.2%

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 31st, there was short interest totalling 2,700 shares, a decline of 18.2% from the January 15th total of 3,300 shares. Approximately 0.1% of the shares of the stock are short sold. Based […]

Related Keywords

,Vanguard Group Inc ,Nasdaq ,Anebulo Pharmaceuticals Price Performance ,Anebulo Pharmaceuticals ,News Ratings For Anebulo Pharmaceuticals Daily ,Institutional Investors Weigh In On Anebulo Pharmaceuticals ,Anebulo Pharmaceuticals Inc ,Securities Exchange Commission ,Anebulo Pharmaceuticals Company Profile ,Get Free Report ,Free Report ,Anebulo Pharmaceuticals Daily ,Nasdaq Aneb ,Maneb ,Medical ,Stocks ,Options ,Put ,Call ,